Noteworthy

Dec 01, 2010
Pharmaceutical Executive
Pharm Exec's Pipeline Report 2020
Dec 01, 2010
Pharmaceutical Executive
Republican gains in Congress create uncertainty for health reform, drug regulation, and biomedical research
Dec 01, 2010
Pharmaceutical Executive
Stepped-up enforcement of the Foreign Corrupt Practices Act requires enhanced global coordination of compliance
Dec 01, 2010
Pharmaceutical Executive
Pharm Exec's Pipeline Report 2023
Dec 01, 2010
Pharmaceutical Executive
The end of anther year is an appropriate time to highlight the march of time—and the transitions that accompany it
Dec 01, 2010
Pharmaceutical Executive
Pharm Exec's Pipeline Report 2024
Dec 01, 2010
Pharmaceutical Executive
The new investigative journalism organization recently took an in-depth look at pharma with its "Dollars for Docs" report. In return, Pharm Exec takes a look back at ProPublica
Dec 01, 2010
Pharmaceutical Executive
By Pharmaceutical Executive Editors
Healthcare marketing in today's post-recession economy is not about one-size-fits-all vehicles, but rather about bringing your prouct into consumers' lives in a series of personal, non-invasive ways
Dec 01, 2010
Pharmaceutical Executive
Pharm Exec's Pipeline Report 2017
Dec 01, 2010
Pharmaceutical Executive
Pharm Exec's Pipeline Report 2012
native1_300x100
lorem ipsum